PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors
Maneno muhimu
Kikemikali
Maelezo
This study will be a retrospective review of patients in the tumor registry with lung and gastrointestinal tumors, not limited to but including small and non-small cell lung cancers, stomach cancer, small intestinal cancer, colon cancer, rectal cancer, liver and intrahepatic bile duct cancers, gallbladder and extrahepatic bile duct cancers, and pancreatic cancer.
There will be a maximum of 10,000 charts/records that will be reviewed to compile the data. Data to be collected will include patients' name, medical record number, date of birth, race, ethnicity, gender, medical history, medications, vital and performance status, vital signs including weight and body mass index, date of cancer diagnosis, clinical and pathologic stage, pathology, treatment course, prior treatment, location of primary lesion, and smoking history. CT and PET findings to be reviewed include the number of involved lymph nodes, size of primary tumor, average/maximum PET avidity in both the primary tumor and involved lymph nodes.
Tarehe
Imethibitishwa Mwisho: | 05/31/2020 |
Iliyowasilishwa Kwanza: | 05/13/2018 |
Uandikishaji uliokadiriwa Uliwasilishwa: | 06/20/2018 |
Iliyotumwa Kwanza: | 06/25/2018 |
Sasisho la Mwisho Liliwasilishwa: | 06/24/2020 |
Sasisho la Mwisho Lilichapishwa: | 06/25/2020 |
Tarehe halisi ya kuanza kwa masomo: | 11/25/2013 |
Tarehe ya Kukamilisha Msingi iliyokadiriwa: | 05/25/2023 |
Tarehe ya Kukamilisha Utafiti: | 02/14/2025 |
Hali au ugonjwa
Uingiliaji / matibabu
Other: Retrospective study
Awamu
Vigezo vya Kustahiki
Zama zinazostahiki Kujifunza | 18 Years Kwa 18 Years |
Jinsia Inastahiki Kujifunza | All |
Njia ya sampuli | Non-Probability Sample |
Hupokea Wajitolea wa Afya | Ndio |
Vigezo | Inclusion Criteria: 1. Patients with histologically proven lung and gastrointestinal cancers, stages I-IV with PET and/or CT within 6 weeks of diagnosis. 2. Patients are greater than 18 years of age. 3. Patients understand a written informed consent document and are willing to sign the consent form. Exclusion Criteria: 1. Pregnant or lactating women, as treatment involves unforeseeable risks to the embryo or fetus. 2. Children (under age of 18) |
Matokeo
Hatua za Matokeo ya Msingi
1. POTENTIAL BENEFITS [10 years]